We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $103M
1-Year Est. Return 77.32%
This Fund
S&P 500
This Quarter Est. Return
-3.19%
1 Year Est. Return
+77.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
-$17.5M
Cap. Flow
-$2.25M
Cap. Flow %
-2.19%
Top 10 Hldgs %
35.28%
Holding
169
New
46
Increased
35
Reduced
35
Closed
32

Top Buys

Rank Stock Value
1
DRVN icon
Driven Brands
DRVN
+$8.81M
2
RVMD icon
Revolution Medicines
RVMD
+$6.74M
3
ICLR icon
Icon
ICLR
+$2.42M
4
TRIP icon
TripAdvisor
TRIP
+$2.21M
5
ELME
Elme Communities
ELME
+$2.17M

Top Sells

Rank Stock Value
1
GDEN
Golden Entertainment
GDEN
+$5.71M
2
CLMT icon
Calumet Specialty Products
CLMT
+$5.34M
3
WBD icon
Warner Bros
WBD
+$4.62M
4
RNAM
Avidity Biosciences
RNAM
+$3.9M
5
RPTX
Repare Therapeutics
RPTX
+$3.35M

Sector Composition

Rank Sector Weight
1 Healthcare 29.22%
2 Consumer Discretionary 17.78%
3 Real Estate 12.14%
4 Financials 8.26%
5 Technology 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OACC
51
Oaktree Acquisition Corp III Life Sciences
OACC
$263M
$424K 0.41%
61,188
+21,156
+53% +$225K
CRBP icon
52
Corbus Pharmaceuticals
CRBP
$168M
$421K 0.41%
+44,840
New +$378K
GTERU
53
Globa Terra Acquisition Corp Units
GTERU
$158M
$420K 0.41%
40,361
– –
NWAX.U
54
New America Acquisition I Corp Units
NWAX.U
$414K 0.4%
40,000
– –
IMMR icon
55
Immersion
IMMR
$256M
$410K 0.4%
+75,000
New +$473K
OKUR
56
OnKure Therapeutics
OKUR
$164M
$393K 0.38%
95,000
-50,000
-34% -$154K
STRS icon
57
Stratus Properties
STRS
$159M
$383K 0.37%
+12,546
New +$363K
YEXT icon
58
Yext
YEXT
$554M
$381K 0.37%
99,328
-486,032
-83% -$2.92M
ACET icon
59
Adicet Bio
ACET
$75.3M
$381K 0.37%
56,000
+30,999
+124% +$232K
LSTA icon
60
Lisata Therapeutics
LSTA
$13.1M
$376K 0.37%
+75,000
New +$310K
LNSR icon
61
LENSAR
LNSR
$66M
$375K 0.36%
63,000
+4,000
+7% +$43.5K
IKT icon
62
Inhibikase Therapeutics
IKT
$369M
$370K 0.36%
+220,000
New +$391K
AIV
63
Aimco
AIV
$377M
$366K 0.36%
+90,000
New +$471K
CNTA
64
DELISTED
Centessa Pharmaceuticals
CNTA
$357K 0.35%
+9,000
New +$230K
EM
65
DELISTED
Smart Share Global Ltd
EM
$347K 0.34%
307,000
-169,600
-36% -$194K
FWRD icon
66
CALL
Forward Air
FWRD
$466M
$336K 0.33%
20,100
-2,200
-10% -$53.5K
DMIIU
67
Drugs Made In America Acquisition II Corp Unit
DMIIU
$327K 0.32%
55,612
+23,061
+71% +$232K
FERA
68
Fifth Era Acquisition Corp I
FERA
$326M
$319K 0.31%
30,990
-2,468
-7% -$25.4K
SSP icon
69
E.W. Scripps
SSP
$271M
$318K 0.31%
+85,490
New +$316K
SOC icon
70
Sable Offshore Corp
SOC
$843M
$314K 0.31%
19,000
– –
TMQ
71
Trilogy Metals
TMQ
$536M
$312K 0.3%
87,000
– –
SEER icon
72
Seer Inc
SEER
$108M
$310K 0.3%
184,302
+164,302
+822% +$304K
EVC icon
73
Entravision Communication
EVC
$1.02B
$297K 0.29%
100,000
+10,000
+11% +$30.7K
FDMT icon
74
4D Molecular Therapeutics
FDMT
$543M
$293K 0.28%
31,465
-7,200
-19% -$62.7K
PLRX icon
75
Pliant Therapeutics
PLRX
$66.9M
$284K 0.28%
225,000
– –
1 2
3
4 5

Similar funds

EFT
Envision Financial Transparency Greensboro, North Carolina $103M AUM
GWL
Generations Wealth LLC Mason, Ohio $103M AUM
CC
Caspian Capital New York $103M AUM
ABLA
Alan B. Lancz & Associates Toledo, Ohio $103M AUM 31.99% 1-Year Est. Return
SPCM
Stoic Point Capital Management Palo Alto, California $103M AUM
OPAM
Olympus Peak Asset Management Greenwich, Connecticut $103M AUM 58.06% 1-Year Est. Return
ES
ETF Store Overland Park, Kansas $103M AUM 15.78% 1-Year Est. Return
IMT
Investment Management Trust Fitchburg, Massachusetts $103M AUM

Rangeley Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Rangeley Capital held 169 positions worth $103M, down 15% from $120M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Rangeley Capital's Q1 2026 filing shows 46 new, 35 increased, 35 reduced and 32 closed positions. Its largest new stake was Driven Brands: 625,500 shares worth $7.89M. The largest sale was Golden Entertainment, an estimated $5.71M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Real Estate.

  • Rangeley Capital's largest Q1 2026 buy was Driven Brands: 625,500 shares worth $7.89M.
  • Rangeley Capital added most to Janux Therapeutics in Q1 2026, an estimated $1.33M increase.
  • Rangeley Capital's biggest Q1 2026 reduction was Calumet Specialty Products, cutting an estimated $5.34M.
  • Rangeley Capital fully exited Golden Entertainment in Q1 2026, selling an estimated $5.71M.
  • Rangeley Capital's ten largest holdings make up 35% of its $103M portfolio in Q1 2026.
  • Rangeley Capital opened 46 new positions and closed 32 in Q1 2026.
  • Rangeley Capital's portfolio value fell 15% quarter-over-quarter to $103M.

Based on Rangeley Capital's 13F filing for Q1 2026, filed 15 May 2026.